Fraunhofer USA Center for Molecular Biotechnology Awarded National Institutes of Health (NIH) Contract for "Vaccine Technologies to Advance Next Generation Anthrax Vaccines"
Published: Dec 04, 2012
NEWARK, Del.--(BUSINESS WIRE)--Fraunhofer Center for Molecular Biotechnology (FhCMB) announced today that it has been awarded a contract from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for developing vaccine technologies to advance the next generation of Anthrax vaccines. For the first year, Fraunhofer will receive $1.76 million. The total funding could be up to $ 9.9 million depending on contract options exercised.